SequelSEC

BioScience Health Innovations, Inc. BHIC

Services-Computer Processing & Data Preparation · CIK 0001784440 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$4.49M
Fiscal year ended 2026-06-30
Operating income
-$613.24K
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$43.92MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$3.86Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income68.4×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue7.7×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity29.7×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Computer Processing & Data Preparation filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Revenue YoY growth208.3%87th
Operating margin12.6%84th
Gross margin57.0%41th

BioScience Health Innovations, Inc. (BHIC) reported revenue of $4.49M and net income of -$658.07K for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from BioScience Health Innovations, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Processing & Data Preparation.

Income

BioScience Health Innovations, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$4.49M
Cost of revenue$2.08M
Gross profit$2.42M
Operating income-$613.24K
Net income-$658.07K
Research & development$111.06K
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

BioScience Health Innovations, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$712.38K
Total assets$2.14M
Current assets$1.99M
Total liabilities$301.21K
Current liabilitiesUnavailable
Total equity incl. NCI$1.83M
Temporary (mezzanine) equityUnavailable
Inventory$797.18K
Accounts receivable$396.90K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$9.72K

Cash flow

BioScience Health Innovations, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$1.54M
Capital expendituresUnavailable
Investing cash flow-$37.74K
Financing cash flow$985.84K
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

BioScience Health Innovations, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin53.8%
Operating margin-13.7%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratioUnavailable
Revenue YoY growth7.8%
Net margin-14.7%
R&D / revenue2.5%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BHIC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-03-30View SEC filing
10-Q · Filed 2025-10-27View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ADP ALIS APLD AUUD AVAI BIRD CARG CARS CLVT CRCW DTCX DTST

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.